nodes	percent_of_prediction	percent_of_DWPC	metapath
Mupirocin—IARS—embryo—testicular cancer	0.0755	0.325	CbGeAlD
Mupirocin—IARS—gonad—testicular cancer	0.0512	0.221	CbGeAlD
Mupirocin—IARS—female gonad—testicular cancer	0.0416	0.179	CbGeAlD
Mupirocin—IARS—testis—testicular cancer	0.0369	0.159	CbGeAlD
Mupirocin—IARS—lymph node—testicular cancer	0.0268	0.115	CbGeAlD
Mupirocin—Ulcerative stomatitis—Dactinomycin—testicular cancer	0.0248	0.0322	CcSEcCtD
Mupirocin—Cellulitis—Vinblastine—testicular cancer	0.016	0.0208	CcSEcCtD
Mupirocin—Mouth ulceration—Chlorambucil—testicular cancer	0.0143	0.0186	CcSEcCtD
Mupirocin—Tenderness—Bleomycin—testicular cancer	0.014	0.0183	CcSEcCtD
Mupirocin—Sensitisation—Epirubicin—testicular cancer	0.013	0.0169	CcSEcCtD
Mupirocin—Sensitisation—Doxorubicin—testicular cancer	0.012	0.0156	CcSEcCtD
Mupirocin—Tenderness—Ifosfamide—testicular cancer	0.012	0.0156	CcSEcCtD
Mupirocin—Furunculosis—Methotrexate—testicular cancer	0.0117	0.0152	CcSEcCtD
Mupirocin—Furunculosis—Epirubicin—testicular cancer	0.0109	0.0142	CcSEcCtD
Mupirocin—Ulcerative stomatitis—Methotrexate—testicular cancer	0.0107	0.014	CcSEcCtD
Mupirocin—Tenderness—Cisplatin—testicular cancer	0.0103	0.0135	CcSEcCtD
Mupirocin—Mouth ulceration—Dactinomycin—testicular cancer	0.0103	0.0135	CcSEcCtD
Mupirocin—Furuncle—Methotrexate—testicular cancer	0.0101	0.0132	CcSEcCtD
Mupirocin—Furunculosis—Doxorubicin—testicular cancer	0.0101	0.0131	CcSEcCtD
Mupirocin—Ulcerative stomatitis—Epirubicin—testicular cancer	0.01	0.0131	CcSEcCtD
Mupirocin—Cellulitis—Cisplatin—testicular cancer	0.00993	0.0129	CcSEcCtD
Mupirocin—Furuncle—Epirubicin—testicular cancer	0.00946	0.0123	CcSEcCtD
Mupirocin—Pain—Carboplatin—testicular cancer	0.00939	0.0122	CcSEcCtD
Mupirocin—Ulcerative stomatitis—Doxorubicin—testicular cancer	0.00929	0.0121	CcSEcCtD
Mupirocin—Cellulitis—Etoposide—testicular cancer	0.0091	0.0118	CcSEcCtD
Mupirocin—Furuncle—Doxorubicin—testicular cancer	0.00875	0.0114	CcSEcCtD
Mupirocin—Swelling—Ifosfamide—testicular cancer	0.00862	0.0112	CcSEcCtD
Mupirocin—Mouth ulceration—Etoposide—testicular cancer	0.00748	0.00974	CcSEcCtD
Mupirocin—Haemoglobin—Vinblastine—testicular cancer	0.00732	0.00954	CcSEcCtD
Mupirocin—Haemorrhage—Vinblastine—testicular cancer	0.00729	0.00949	CcSEcCtD
Mupirocin—Pharyngitis—Vinblastine—testicular cancer	0.00723	0.00942	CcSEcCtD
Mupirocin—Swelling—Etoposide—testicular cancer	0.00681	0.00886	CcSEcCtD
Mupirocin—Angioedema—Chlorambucil—testicular cancer	0.00633	0.00824	CcSEcCtD
Mupirocin—Haemoglobin—Bleomycin—testicular cancer	0.00619	0.00806	CcSEcCtD
Mupirocin—Haemorrhage—Bleomycin—testicular cancer	0.00615	0.00801	CcSEcCtD
Mupirocin—Stinging—Epirubicin—testicular cancer	0.00572	0.00745	CcSEcCtD
Mupirocin—Pharyngitis—Dactinomycin—testicular cancer	0.0057	0.00742	CcSEcCtD
Mupirocin—Erythema—Bleomycin—testicular cancer	0.00536	0.00698	CcSEcCtD
Mupirocin—Stinging—Doxorubicin—testicular cancer	0.0053	0.0069	CcSEcCtD
Mupirocin—Haemoglobin—Ifosfamide—testicular cancer	0.00529	0.00688	CcSEcCtD
Mupirocin—Haemorrhage—Ifosfamide—testicular cancer	0.00526	0.00685	CcSEcCtD
Mupirocin—Cellulitis—Epirubicin—testicular cancer	0.0051	0.00664	CcSEcCtD
Mupirocin—Erythema—Dactinomycin—testicular cancer	0.005	0.00651	CcSEcCtD
Mupirocin—Pain—Chlorambucil—testicular cancer	0.00483	0.00629	CcSEcCtD
Mupirocin—Immune system disorder—Ifosfamide—testicular cancer	0.00475	0.00619	CcSEcCtD
Mupirocin—Cellulitis—Doxorubicin—testicular cancer	0.00472	0.00614	CcSEcCtD
Mupirocin—Cough—Bleomycin—testicular cancer	0.00468	0.00609	CcSEcCtD
Mupirocin—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00462	0.00602	CcSEcCtD
Mupirocin—Dermatitis contact—Epirubicin—testicular cancer	0.00458	0.00597	CcSEcCtD
Mupirocin—Erythema—Ifosfamide—testicular cancer	0.00458	0.00596	CcSEcCtD
Mupirocin—Urticaria—Chlorambucil—testicular cancer	0.00449	0.00584	CcSEcCtD
Mupirocin—Mouth ulceration—Methotrexate—testicular cancer	0.00448	0.00583	CcSEcCtD
Mupirocin—Abdominal pain—Chlorambucil—testicular cancer	0.00447	0.00582	CcSEcCtD
Mupirocin—Pain—Vinblastine—testicular cancer	0.00443	0.00577	CcSEcCtD
Mupirocin—Anaphylactic shock—Bleomycin—testicular cancer	0.00437	0.00569	CcSEcCtD
Mupirocin—Dermatitis contact—Doxorubicin—testicular cancer	0.00424	0.00552	CcSEcCtD
Mupirocin—Gastrointestinal pain—Vinblastine—testicular cancer	0.00423	0.00551	CcSEcCtD
Mupirocin—Mouth ulceration—Epirubicin—testicular cancer	0.00419	0.00546	CcSEcCtD
Mupirocin—Angioedema—Ifosfamide—testicular cancer	0.00418	0.00545	CcSEcCtD
Mupirocin—Hypersensitivity—Chlorambucil—testicular cancer	0.00416	0.00542	CcSEcCtD
Mupirocin—Immune system disorder—Cisplatin—testicular cancer	0.0041	0.00533	CcSEcCtD
Mupirocin—Abdominal pain—Vinblastine—testicular cancer	0.00409	0.00533	CcSEcCtD
Mupirocin—Pruritus—Chlorambucil—testicular cancer	0.004	0.00521	CcSEcCtD
Mupirocin—Cough—Ifosfamide—testicular cancer	0.004	0.0052	CcSEcCtD
Mupirocin—Erythema—Cisplatin—testicular cancer	0.00395	0.00514	CcSEcCtD
Mupirocin—Mouth ulceration—Doxorubicin—testicular cancer	0.00388	0.00505	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.00387	0.00504	CcSEcCtD
Mupirocin—Diarrhoea—Chlorambucil—testicular cancer	0.00387	0.00503	CcSEcCtD
Mupirocin—Hypersensitivity—Vinblastine—testicular cancer	0.00381	0.00497	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Methotrexate—testicular cancer	0.00381	0.00496	CcSEcCtD
Mupirocin—Immune system disorder—Etoposide—testicular cancer	0.00375	0.00489	CcSEcCtD
Mupirocin—Eczema—Epirubicin—testicular cancer	0.00375	0.00488	CcSEcCtD
Mupirocin—Pain—Bleomycin—testicular cancer	0.00374	0.00487	CcSEcCtD
Mupirocin—Anaphylactic shock—Ifosfamide—testicular cancer	0.00374	0.00487	CcSEcCtD
Mupirocin—Skin disorder—Ifosfamide—testicular cancer	0.00363	0.00473	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Epirubicin—testicular cancer	0.00357	0.00465	CcSEcCtD
Mupirocin—Diarrhoea—Vinblastine—testicular cancer	0.00354	0.00461	CcSEcCtD
Mupirocin—Dysgeusia—Etoposide—testicular cancer	0.00354	0.00461	CcSEcCtD
Mupirocin—Pain—Dactinomycin—testicular cancer	0.00349	0.00454	CcSEcCtD
Mupirocin—Urticaria—Bleomycin—testicular cancer	0.00347	0.00452	CcSEcCtD
Mupirocin—Eczema—Doxorubicin—testicular cancer	0.00347	0.00451	CcSEcCtD
Mupirocin—Dizziness—Vinblastine—testicular cancer	0.00342	0.00446	CcSEcCtD
Mupirocin—Nausea—Chlorambucil—testicular cancer	0.00336	0.00437	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00334	0.00435	CcSEcCtD
Mupirocin—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00333	0.00434	CcSEcCtD
Mupirocin—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.0033	0.0043	CcSEcCtD
Mupirocin—Headache—Vinblastine—testicular cancer	0.00324	0.00422	CcSEcCtD
Mupirocin—Abdominal pain—Dactinomycin—testicular cancer	0.00322	0.0042	CcSEcCtD
Mupirocin—Anaphylactic shock—Cisplatin—testicular cancer	0.00322	0.0042	CcSEcCtD
Mupirocin—Hypersensitivity—Bleomycin—testicular cancer	0.00322	0.0042	CcSEcCtD
Mupirocin—Pain—Ifosfamide—testicular cancer	0.0032	0.00416	CcSEcCtD
Mupirocin—Cough—Etoposide—testicular cancer	0.00316	0.00411	CcSEcCtD
Mupirocin—Skin disorder—Cisplatin—testicular cancer	0.00313	0.00408	CcSEcCtD
Mupirocin—Pruritus—Bleomycin—testicular cancer	0.00309	0.00403	CcSEcCtD
Mupirocin—Dry skin—Epirubicin—testicular cancer	0.00309	0.00402	CcSEcCtD
Mupirocin—Nausea—Vinblastine—testicular cancer	0.00308	0.004	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00306	0.00398	CcSEcCtD
Mupirocin—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00306	0.00398	CcSEcCtD
Mupirocin—Hypersensitivity—Dactinomycin—testicular cancer	0.003	0.00391	CcSEcCtD
Mupirocin—Urticaria—Ifosfamide—testicular cancer	0.00297	0.00387	CcSEcCtD
Mupirocin—Abdominal pain—Ifosfamide—testicular cancer	0.00295	0.00385	CcSEcCtD
Mupirocin—Anaphylactic shock—Etoposide—testicular cancer	0.00295	0.00384	CcSEcCtD
Mupirocin—Skin disorder—Etoposide—testicular cancer	0.00287	0.00373	CcSEcCtD
Mupirocin—Dry skin—Doxorubicin—testicular cancer	0.00285	0.00372	CcSEcCtD
Mupirocin—Diarrhoea—Dactinomycin—testicular cancer	0.00279	0.00363	CcSEcCtD
Mupirocin—Rash—Bleomycin—testicular cancer	0.00276	0.00359	CcSEcCtD
Mupirocin—Pain—Cisplatin—testicular cancer	0.00276	0.00359	CcSEcCtD
Mupirocin—Dermatitis—Bleomycin—testicular cancer	0.00275	0.00359	CcSEcCtD
Mupirocin—Hypersensitivity—Ifosfamide—testicular cancer	0.00275	0.00359	CcSEcCtD
Mupirocin—Pruritus—Ifosfamide—testicular cancer	0.00264	0.00344	CcSEcCtD
Mupirocin—Epistaxis—Methotrexate—testicular cancer	0.00261	0.0034	CcSEcCtD
Mupirocin—Nausea—Bleomycin—testicular cancer	0.0026	0.00338	CcSEcCtD
Mupirocin—Rash—Dactinomycin—testicular cancer	0.00257	0.00335	CcSEcCtD
Mupirocin—Diarrhoea—Ifosfamide—testicular cancer	0.00256	0.00333	CcSEcCtD
Mupirocin—Pain—Etoposide—testicular cancer	0.00252	0.00329	CcSEcCtD
Mupirocin—Haemoglobin—Methotrexate—testicular cancer	0.0025	0.00326	CcSEcCtD
Mupirocin—Haemorrhage—Methotrexate—testicular cancer	0.00249	0.00324	CcSEcCtD
Mupirocin—Dizziness—Ifosfamide—testicular cancer	0.00247	0.00322	CcSEcCtD
Mupirocin—Pharyngitis—Methotrexate—testicular cancer	0.00247	0.00322	CcSEcCtD
Mupirocin—Epistaxis—Epirubicin—testicular cancer	0.00245	0.00319	CcSEcCtD
Mupirocin—Nausea—Dactinomycin—testicular cancer	0.00242	0.00315	CcSEcCtD
Mupirocin—Gastrointestinal pain—Etoposide—testicular cancer	0.00241	0.00314	CcSEcCtD
Mupirocin—Hypersensitivity—Cisplatin—testicular cancer	0.00237	0.00309	CcSEcCtD
Mupirocin—Rash—Ifosfamide—testicular cancer	0.00236	0.00307	CcSEcCtD
Mupirocin—Dermatitis—Ifosfamide—testicular cancer	0.00235	0.00307	CcSEcCtD
Mupirocin—Urticaria—Etoposide—testicular cancer	0.00234	0.00305	CcSEcCtD
Mupirocin—Haemoglobin—Epirubicin—testicular cancer	0.00234	0.00305	CcSEcCtD
Mupirocin—Rhinitis—Epirubicin—testicular cancer	0.00233	0.00304	CcSEcCtD
Mupirocin—Abdominal pain—Etoposide—testicular cancer	0.00233	0.00304	CcSEcCtD
Mupirocin—Haemorrhage—Epirubicin—testicular cancer	0.00233	0.00303	CcSEcCtD
Mupirocin—Pharyngitis—Epirubicin—testicular cancer	0.00231	0.00301	CcSEcCtD
Mupirocin—Epistaxis—Doxorubicin—testicular cancer	0.00226	0.00295	CcSEcCtD
Mupirocin—Immune system disorder—Methotrexate—testicular cancer	0.00225	0.00293	CcSEcCtD
Mupirocin—Nausea—Ifosfamide—testicular cancer	0.00222	0.00289	CcSEcCtD
Mupirocin—Diarrhoea—Cisplatin—testicular cancer	0.0022	0.00287	CcSEcCtD
Mupirocin—Hypersensitivity—Etoposide—testicular cancer	0.00217	0.00283	CcSEcCtD
Mupirocin—Erythema—Methotrexate—testicular cancer	0.00217	0.00282	CcSEcCtD
Mupirocin—Haemoglobin—Doxorubicin—testicular cancer	0.00217	0.00282	CcSEcCtD
Mupirocin—Rhinitis—Doxorubicin—testicular cancer	0.00216	0.00281	CcSEcCtD
Mupirocin—Haemorrhage—Doxorubicin—testicular cancer	0.00215	0.00281	CcSEcCtD
Mupirocin—Pharyngitis—Doxorubicin—testicular cancer	0.00214	0.00278	CcSEcCtD
Mupirocin—Dysgeusia—Methotrexate—testicular cancer	0.00212	0.00276	CcSEcCtD
Mupirocin—Immune system disorder—Epirubicin—testicular cancer	0.0021	0.00274	CcSEcCtD
Mupirocin—Pruritus—Etoposide—testicular cancer	0.00209	0.00272	CcSEcCtD
Mupirocin—Rash—Cisplatin—testicular cancer	0.00203	0.00265	CcSEcCtD
Mupirocin—Dermatitis—Cisplatin—testicular cancer	0.00203	0.00264	CcSEcCtD
Mupirocin—Erythema—Epirubicin—testicular cancer	0.00203	0.00264	CcSEcCtD
Mupirocin—Diarrhoea—Etoposide—testicular cancer	0.00202	0.00263	CcSEcCtD
Mupirocin—Dysgeusia—Epirubicin—testicular cancer	0.00199	0.00259	CcSEcCtD
Mupirocin—Dizziness—Etoposide—testicular cancer	0.00195	0.00254	CcSEcCtD
Mupirocin—Immune system disorder—Doxorubicin—testicular cancer	0.00195	0.00253	CcSEcCtD
Mupirocin—Nausea—Cisplatin—testicular cancer	0.00191	0.00249	CcSEcCtD
Mupirocin—Cough—Methotrexate—testicular cancer	0.00189	0.00246	CcSEcCtD
Mupirocin—Erythema—Doxorubicin—testicular cancer	0.00188	0.00244	CcSEcCtD
Mupirocin—Rash—Etoposide—testicular cancer	0.00186	0.00242	CcSEcCtD
Mupirocin—Dermatitis—Etoposide—testicular cancer	0.00186	0.00242	CcSEcCtD
Mupirocin—Headache—Etoposide—testicular cancer	0.00185	0.00241	CcSEcCtD
Mupirocin—Dysgeusia—Doxorubicin—testicular cancer	0.00184	0.00239	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00183	0.00238	CcSEcCtD
Mupirocin—Cough—Epirubicin—testicular cancer	0.00177	0.0023	CcSEcCtD
Mupirocin—Anaphylactic shock—Methotrexate—testicular cancer	0.00177	0.0023	CcSEcCtD
Mupirocin—Nausea—Etoposide—testicular cancer	0.00175	0.00228	CcSEcCtD
Mupirocin—Skin disorder—Methotrexate—testicular cancer	0.00172	0.00224	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00171	0.00223	CcSEcCtD
Mupirocin—Dry mouth—Epirubicin—testicular cancer	0.00169	0.0022	CcSEcCtD
Mupirocin—Anaphylactic shock—Epirubicin—testicular cancer	0.00165	0.00215	CcSEcCtD
Mupirocin—Cough—Doxorubicin—testicular cancer	0.00164	0.00213	CcSEcCtD
Mupirocin—Skin disorder—Epirubicin—testicular cancer	0.00161	0.00209	CcSEcCtD
Mupirocin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00159	0.00207	CcSEcCtD
Mupirocin—Dry mouth—Doxorubicin—testicular cancer	0.00156	0.00203	CcSEcCtD
Mupirocin—Anaphylactic shock—Doxorubicin—testicular cancer	0.00153	0.00199	CcSEcCtD
Mupirocin—Pain—Methotrexate—testicular cancer	0.00151	0.00197	CcSEcCtD
Mupirocin—Skin disorder—Doxorubicin—testicular cancer	0.00149	0.00194	CcSEcCtD
Mupirocin—Gastrointestinal pain—Methotrexate—testicular cancer	0.00145	0.00188	CcSEcCtD
Mupirocin—Pain—Epirubicin—testicular cancer	0.00141	0.00184	CcSEcCtD
Mupirocin—Urticaria—Methotrexate—testicular cancer	0.0014	0.00183	CcSEcCtD
Mupirocin—Abdominal pain—Methotrexate—testicular cancer	0.0014	0.00182	CcSEcCtD
Mupirocin—Gastrointestinal pain—Epirubicin—testicular cancer	0.00135	0.00176	CcSEcCtD
Mupirocin—Urticaria—Epirubicin—testicular cancer	0.00131	0.00171	CcSEcCtD
Mupirocin—Pain—Doxorubicin—testicular cancer	0.00131	0.0017	CcSEcCtD
Mupirocin—Abdominal pain—Epirubicin—testicular cancer	0.00131	0.0017	CcSEcCtD
Mupirocin—Hypersensitivity—Methotrexate—testicular cancer	0.0013	0.0017	CcSEcCtD
Mupirocin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00125	0.00163	CcSEcCtD
Mupirocin—Pruritus—Methotrexate—testicular cancer	0.00125	0.00163	CcSEcCtD
Mupirocin—Hypersensitivity—Epirubicin—testicular cancer	0.00122	0.00159	CcSEcCtD
Mupirocin—Urticaria—Doxorubicin—testicular cancer	0.00122	0.00158	CcSEcCtD
Mupirocin—Abdominal pain—Doxorubicin—testicular cancer	0.00121	0.00158	CcSEcCtD
Mupirocin—Diarrhoea—Methotrexate—testicular cancer	0.00121	0.00158	CcSEcCtD
Mupirocin—Pruritus—Epirubicin—testicular cancer	0.00117	0.00152	CcSEcCtD
Mupirocin—Dizziness—Methotrexate—testicular cancer	0.00117	0.00152	CcSEcCtD
Mupirocin—Diarrhoea—Epirubicin—testicular cancer	0.00113	0.00147	CcSEcCtD
Mupirocin—Hypersensitivity—Doxorubicin—testicular cancer	0.00113	0.00147	CcSEcCtD
Mupirocin—Rash—Methotrexate—testicular cancer	0.00111	0.00145	CcSEcCtD
Mupirocin—Dermatitis—Methotrexate—testicular cancer	0.00111	0.00145	CcSEcCtD
Mupirocin—Headache—Methotrexate—testicular cancer	0.00111	0.00144	CcSEcCtD
Mupirocin—Dizziness—Epirubicin—testicular cancer	0.00109	0.00142	CcSEcCtD
Mupirocin—Pruritus—Doxorubicin—testicular cancer	0.00108	0.00141	CcSEcCtD
Mupirocin—Nausea—Methotrexate—testicular cancer	0.00105	0.00137	CcSEcCtD
Mupirocin—Diarrhoea—Doxorubicin—testicular cancer	0.00105	0.00136	CcSEcCtD
Mupirocin—Rash—Epirubicin—testicular cancer	0.00104	0.00136	CcSEcCtD
Mupirocin—Dermatitis—Epirubicin—testicular cancer	0.00104	0.00136	CcSEcCtD
Mupirocin—Headache—Epirubicin—testicular cancer	0.00104	0.00135	CcSEcCtD
Mupirocin—Dizziness—Doxorubicin—testicular cancer	0.00101	0.00132	CcSEcCtD
Mupirocin—Nausea—Epirubicin—testicular cancer	0.000983	0.00128	CcSEcCtD
Mupirocin—Rash—Doxorubicin—testicular cancer	0.000965	0.00126	CcSEcCtD
Mupirocin—Dermatitis—Doxorubicin—testicular cancer	0.000964	0.00126	CcSEcCtD
Mupirocin—Headache—Doxorubicin—testicular cancer	0.000959	0.00125	CcSEcCtD
Mupirocin—Nausea—Doxorubicin—testicular cancer	0.000909	0.00118	CcSEcCtD
